Pooled Purchasing Is Poor Answer To Latin American Drug Pricing Worries, Says Industry
Executive Summary
Pooled procurement will not fix problems relating to affordability and access to medicines in South America, says the US pharma industry association, PhRMA, in response to news that Mercosur trade bloc members will join forces to negotiate better prices for medicines.
You may also be interested in...
Mercosur Bets On Joint Pricing Negotiations And Procurement For Lower Prices, But Slams Hep C Companies
Countries in South America have negotiated lower prices for the immunosuppressant tacrolimus and have their sights on high-cost oncology treatments. However, they have slammed companies selling new hepatitis C treatments for their inflexibility.
More Cheer For Biocon-Mylan As Brazil Clears Biosimilar Trastuzumab
Biocon and Mylan have received approval in Brazil for the first biosimilar version of Roche’s Herceptin (trastuzumab). The partners hope to provide an “affordable” option, expanding access to the product in the Latin American nation.
More Cheer For Biocon-Mylan As Brazil Clears Biosimilar Trastuzumab
Biocon and Mylan have received approval in Brazil for the first biosimilar version of Roche’s Herceptin (trastuzumab). The partners hope to provide an “affordable” option, expanding access to the product in the Latin American nation.